Sex, gender, and retinoblastoma: analysis of 4351 patients from 153 countries.
Ido Didi FabianVikas KhetanAndrew W Staceynull Allen FosterDupe S Ademola-PopoolaJesse L BerryNathalie CassouxGuillermo L ChantadaLaila HessissenSrikanta Kumar PadhyTero Tapani KiveläSandra Luna-FinemanFrancis L MunierM Ashwin ReddyDuangnate RojanapornSharon BlumSadik T SheriefSandra E StaffieriTuyisabe TheophileKeith WaddellXunda JiNicholas J AstburyCovadonga BascaranMatthew BurtonMarcia ZondervanRichard J C Bowmannull nullPublished in: Eye (London, England) (2021)
No proof of sex predilection in retinoblastoma was found in the present study, which is estimated to include over half of new retinoblastoma patients worldwide in 2017. A high male to female ratio in Asian countries, India in specific, which may have had an impact on global-level analysis, is likely due to gender discrimination in access to care in these countries, rather than a biological difference between sexes.